November 16, 2020/Cancer

Intraoperative Pan-Enteroscopy on a Patient with 125 cm of Small Bowel

Experts from the Weiss Center treat severe polyposis


Case report

A 27-year-old female occupational therapist from out of state presented to Cleveland Clinic with only 125 cm (about 25% of normal) of remaining small bowel after multiple surgeries and resections due to severe polyposis. She was at risk for short gut syndrome, which is associated with dehydration and malnutrition that may necessitate total parenteral nutrition. She had previously been diagnosed with and surgically treated for Peutz-Jeghers Syndrome (PJS), a hereditary colorectal cancer syndrome that causes hamartomatous polyps, an elevated lifetime cancer risk of 37 to 93% and mucocutaneous pigmentation.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“She came to us with few surgical options remaining,” said David Liska, MD, Director of the Sanford R. Weiss, MD, Center for Hereditary Colorectal Neoplasia at Cleveland Clinic’s Digestive Disease & Surgery Institute. “She was not followed by a registry and so did not have appropriate surveillance.”

Weiss Center caregivers performed an MR enterography that showed massive polyposis of the small bowel. Endoscopic removal was attempted, but adhesions from previous surgeries prevented necessary endoscopic access. Instead, Amit Bhatt, MD, and Dr. Liska performed a “clean sweep,” or intraoperative pan-enteroscopy, a procedure that removes polyps inaccessible on balloon enteroscopy.

“Although she had only 125 cm of small bowel left, we successfully removed 180 polyps through this combined approach, and allowed her to keep her small bowel,” notes Dr. Bhatt, an advanced endoscopy specialist with the Weiss Center. “That’s an extraordinary number, and would only be possible through this team approach. Fortunately none of them were cancerous polyps.”

The patient is doing well and is returning to the Weiss Center for another procedure. Her brother is now a patient as well.

Hereditary colorectal neoplasia

Patients with PJS are often diagnosed in middle childhood or the early teen years and present needing emergency surgery for small bowel obstruction due to polyposis-related intussusception and resulting in bowel ischemia or necrosis. “These patients often require several surgeries over the years,” notes Dr. Liska. “At the Weiss Center, we have a registry that allows us to follow patients very closely to avoid emergency procedures and instead use prophylactic measures to prevent bowel obstructions and cancer.”

Since patients with PJS are also predisposed to several types of cancer, the Weiss Center coordinates screening and surveillance so that cancers can be diagnosed and treated early. The multidisciplinary center’s mission is to prevent death or complications from cancer and to maintain quality of life for patients with hereditary colorectal conditions. Other syndromes of hereditary colorectal neoplasia include familial adenomatous polyposis, PTEN hamartoma tumor syndrome, juvenile polyposis syndrome and Lynch syndrome.

The “clean sweep”

Patients with PJS are at increased risk for intestinal cancer and at high risk for bowel obstructions. The Weiss Center team monitors patients for polyps via enterography and capsule endoscopy with the hope that polyps can be removed endoscopically before they get big enough to cause obstruction or to develop into cancers.

“Sometimes, as in our patient from out of state, they simply cannot be totally removed endoscopically for various reasons,” says Dr. Bhatt. “Then, we use an advanced, team-based method in the OR that allows us to view the entire intestine from mouth to anus using manually guided intraoperative endoscopy to remove polyps and prevent obstructions or cancer.”


James Church, MD, the Weiss Center’s first director, nicknamed this procedure the “clean sweep.” A recent study of 50 Cleveland Clinic patients demonstrated that this procedure decreases the need for emergency laparotomies for small bowel obstruction due to polyp-related intussusception in patients with PJS. Further studies are planned to confirm these results.

The Weiss Center and the Jagelman registry

These studies all draw from a ground-breaking concept. In 1979, Dr. David G. Jagelman established Cleveland Clinic’s Familial Polyposis Registry. His intent was to follow high-risk colorectal patients and families with a personal and/or family history of familial adenomatous polyposis and other similar syndromes. In 1989, hereditary nonpolyposis colorectal cancer was added to the registry.

“Now the registry includes thousands of patients and their families and has allowed us to learn more about the best ways to track and treat these disorders,” says Dr. Liska. For instance, the registry’s presence promotes proactive screening for Lynch syndrome. The Digestive Disease & Surgery Institute, Genomic Medicine Institute, Pathology and Laboratory Medicine Institute and Women’s Health Institute collaborate through the Weiss Center to provide comprehensive and coordinated risk-based screening, surveillance and treatment for patients with Lynch syndrome.

Because these hereditary syndromes are so rare, the Weiss Center receives referrals from all over the world. “We are a one-stop shop for patients. Patients from out of town can get all of their visits in a single day, and we employ three full-time coordinators to ensure the referral process is as easy as possible for physicians and patients.”

Feature image: “Clean Sweep” procedure. Left image show intraoperative enteroscopy transilluminating the small bowel with the silhouette of a polyp outlined. Right images show endoscopic appearance of PJS polyps.


Related Articles

Blood clot
May 17, 2024/Cancer/Research
Managing the Risks of Venous Thromboembolisms in Patients with Cancer

Oral anticoagulants may be beneficial but need to be balanced against bleeding risks

Director of the Novel Cancer Therapeutics Center
May 2, 2024/Cancer/Innovations
Oncology Pharmacovigilance Clinic Expands Specialties

First-of-its-kind clinic for immune-related adverse events supports oncologists in managing severe side effects

Scrambler therapy for nerve pain
April 29, 2024/Cancer
Scrambler Technology Life Changing for Many Patients with Neuropathic Pain

Novel therapy “retrains” the brain to disrupt pain signals

Women's health physician
April 16, 2024/Cancer
Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

Fluorescent imaging during small bowel surgery
April 11, 2024/Cancer/Surgical Oncology
Fluorescence Imaging Augments Surgical Inspection and Palpation for Small Bowel Carcinoid Tumors

Study demonstrates superior visualization of occult primary lesions

microwave ablation of liver tumor
150-Watt, Single-Antenna Microwave Ablation System Demonstrates Safety and Efficacy

New device offers greater tumor control for malignant liver lesions

viral-induced cancer
April 3, 2024/Cancer
Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer